These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31598611)

  • 21. Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.
    Li PH; Jiang H; Zhang WJ; Li YL; Zhao MC; Zhou W; Zhang LY; Tang YD; Dong CZ; Huang ZS; Chen HX; Du ZY
    Eur J Med Chem; 2018 Feb; 145():498-510. PubMed ID: 29335211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.
    Drwal MN; Marinello J; Manzo SG; Wakelin LP; Capranico G; Griffith R
    PLoS One; 2014; 9(12):e114904. PubMed ID: 25489853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha.
    Vilain N; Tsai-Pflugfelder M; Benoit A; Gasser SM; Leroy D
    Nucleic Acids Res; 2003 Oct; 31(19):5714-22. PubMed ID: 14500835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel indeno[1,2-b]pyridinone derivative, a DNA intercalative human topoisomerase IIα catalytic inhibitor, for caspase 3-independent anticancer activity.
    Jeon KH; Park C; Kadayat TM; Shrestha A; Lee ES; Kwon Y
    Chem Commun (Camb); 2017 Jun; 53(51):6864-6867. PubMed ID: 28604852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.
    Mayer C; Janin YL
    Chem Rev; 2014 Feb; 114(4):2313-42. PubMed ID: 24313284
    [No Abstract]   [Full Text] [Related]  

  • 26. Catalytic inhibition of DNA topoisomerase IIalpha by sodium azide.
    Ju R; Mao Y; Glick MJ; Muller MT; Snyder RD
    Toxicol Lett; 2001 Apr; 121(2):119-26. PubMed ID: 11325562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-competitive inhibitors of human DNA topoisomerase IIα with improved antiproliferative activity based on N-phenylpyrrolamide scaffold.
    Skok Ž; Durcik M; Zajec Ž; Gramec Skledar D; Bozovičar K; Pišlar A; Tomašič T; Zega A; Peterlin Mašič L; Kikelj D; Zidar N; Ilaš J
    Eur J Med Chem; 2023 Mar; 249():115116. PubMed ID: 36689894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity.
    Bist G; Park S; Song C; Thapa Magar TB; Shrestha A; Kwon Y; Lee ES
    Eur J Med Chem; 2017 Jun; 133():69-84. PubMed ID: 28384547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β.
    Ortega JA; Arencibia JM; Minniti E; Byl JAW; Franco-Ulloa S; Borgogno M; Genna V; Summa M; Bertozzi SM; Bertorelli R; Armirotti A; Minarini A; Sissi C; Osheroff N; De Vivo M
    J Med Chem; 2020 Nov; 63(21):12873-12886. PubMed ID: 33079544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
    Shapiro AB; Austin CA
    Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase.
    Bakshi RP; Galande S; Muniyappa K
    Crit Rev Biochem Mol Biol; 2001; 36(1):1-37. PubMed ID: 11256504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
    Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
    Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking.
    Taskin T; Yilmaz S; Yildiz I; Yalcin I; Aki E
    SAR QSAR Environ Res; 2012; 23(3-4):345-55. PubMed ID: 22490049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.
    Suzuki H; Ikeda T; Yamagishi T; Nakaike S; Nakane S; Ohsawa M
    Mutat Res; 1995 May; 328(2):151-61. PubMed ID: 7739599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence.
    Kalfalah FM; Mielke C; Christensen MO; Baechler S; Marko D; Boege F
    Mol Nutr Food Res; 2011 May; 55 Suppl 1():S127-42. PubMed ID: 21520487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA.
    Leroy D; Kajava AV; Frei C; Gasser SM
    Biochemistry; 2001 Feb; 40(6):1624-34. PubMed ID: 11327821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvicine functions as novel topoisomerase II poison by binding to ATP pocket.
    Hu CX; Zuo ZL; Xiong B; Ma JG; Geng MY; Lin LP; Jiang HL; Ding J
    Mol Pharmacol; 2006 Nov; 70(5):1593-601. PubMed ID: 16914642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.
    Islam MS; Park S; Song C; Kadi AA; Kwon Y; Rahman AF
    Eur J Med Chem; 2017 Jan; 125():49-67. PubMed ID: 27654394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.